Katherine Murray - May 19, 2022 Form 3 Insider Report for CORE LABORATORIES N V (CLB)

Role: Director
Signature: /s/ Mark D. Tattoli, Attorney-in-fact
Stock symbol: CLB
Transactions as of: May 19, 2022
Transactions value $: $0
Form type: 3
Date filed: 5/27/2022, 04:57 PM
Next filing: Apr 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
holding	CLB	Common Shares						0	May 19, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CLB	Restricted Shares							May 19, 2022	Common Shares	5.49 K	$0.00	Direct	F1

Explanation of Responses:

Id	Content
F1	The Restricted Shares were granted to Ms. Murray upon her election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2022, and will vest, without performance criteria, on April 1, 2023, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.

Content

The Restricted Shares were granted to Ms. Murray upon her election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2022, and will vest, without performance criteria, on April 1, 2023, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.